Name | Epinastine Hydrochloride |
---|---|
Synonyms |
9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-aminhydrochlorid
UNII:GFM415S5XL 9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azépin-3-amine chlorhydrate 9,13b-Dihydro-1H-dibenz[cf]imidazo[1,5-a]azepine hydrochloride,WAL-801Cl 1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine, 9,13b-dihydro-, hydrochloride (1:1) 3-Amino-9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepine Hydrochloride EPINASTINHCL Epinastine hydrochloride Epinastinehydrochloride 1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine,9,13b-dihydro-,hydrochloride T B5 G6&6 BN DN CUT&T&J CZ &&HCl EPIMEDIUM P.E EPINASTINE HCL Epinastine 9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride 1H-DIBENZ[C,F]IMIDAZO[1,5-A]AZEPIN-3-AMINE,9,13B-DIHYDRO-, HYDROCHLORIDE (1:1) 9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine hydrochloride (1:1) Epinastin HCl |
Description | Epinastine hydrochloride (WAL801 hydrochloride) is an antihistamine and mast cell stabilizer. Epinastine hydrochloride is a potent, selective and orally-active histamine H1 receptor antagonist. Epinastine hydrochloride also inhibits IL-8 release and has an antiallergic action[1][2][3]. |
---|---|
Related Catalog | |
References |
Density | 1.32g/cm3 |
---|---|
Boiling Point | 428ºC at 760 mmHg |
Melting Point | >270ºC |
Molecular Formula | C16H16ClN3 |
Molecular Weight | 285.771 |
Flash Point | 212.7ºC |
Exact Mass | 285.103271 |
PSA | 41.62000 |
LogP | 3.46970 |
Vapour Pressure | 1.56E-07mmHg at 25°C |
Storage condition | 2-8°C |
Water Solubility | H2O: soluble38mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 |
Precautionary Statements | P301 + P310 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Hazard Codes | T: Toxic; |
Risk Phrases | R25 |
Safety Phrases | 45 |
RIDADR | UN 2811 6 |
RTECS | HO4360000 |
HS Code | 2933990090 |
~90% 108929-04-0 |
Literature: USV LIMITED Patent: WO2009/63504 A2, 2009 ; Location in patent: Page/Page column 25 ; |
~% 108929-04-0 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 40, # 4 p. 440 - 446 |
~% 108929-04-0 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 40, # 4 p. 440 - 446 |
~% 108929-04-0 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 40, # 4 p. 440 - 446 |
~% 108929-04-0 |
Literature: Arzneimittel-Forschung/Drug Research, , vol. 40, # 4 p. 440 - 446 |
Precursor 4 | |
---|---|
DownStream 0 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |